Candidate genetic markers and therapeutic targets in hereditary and sporadic prostate cancer

被引：0
|
作者：
Berthon, P [1 ]
机构：
[1] UroGene, F-91058 Evry, France
来源：
PROSTATE AND RENAL CANCER, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION AND BASIC RESEARCH: AND UPDATE | 2003年
关键词：
D O I：
暂无
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：128 / 135
页数：8
相关论文
共 50 条
  • [1] Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer
    Wiklund, F
    Jonsson, BA
    Brookes, AJ
    Strömqvist, L
    Adolfsson, J
    Emanuelsson, M
    Adami, HO
    Augustsson-Bälter, K
    Grönberg, H
    CLINICAL CANCER RESEARCH, 2004, 10 (21) : 7150 - 7156
  • [2] Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer
    Welsh, JB
    Sapinoso, LM
    Su, AI
    Kern, SG
    Wang-Rodriguez, J
    Moskaluk, CA
    Frierson, HF
    Hampton, GM
    CANCER RESEARCH, 2001, 61 (16) : 5974 - 5978
  • [3] Allelic imbalance in hereditary and sporadic prostate cancer
    Verhage, BAJ
    van Houwelingen, K
    Ruijter, TEG
    Kiemeney, LA
    Schalken, JA
    PROSTATE, 2003, 54 (01): : 50 - 57
  • [4] Blood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer
    Lissbrant, IF
    Lissbrant, E
    Damber, JE
    Bergh, A
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2001, 35 (06): : 437 - 452
  • [5] Translation of cancer markers to therapeutic targets
    Zhang, W
    ONCOLOGY RESEARCH, 2006, 15 (10-12) : 457 - 458
  • [6] Challenges in validating candidate therapeutic targets in cancer
    Settleman, Jeffrey
    Sawyers, Charles L.
    Hunter, Tony
    ELIFE, 2018, 7
  • [7] Genetic etiology of hereditary prostate cancer
    Langeberg, Wendy J.
    Isaacs, William B.
    Stanford, Janet L.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 4101 - 4110
  • [8] Hereditary prostate cancer and other genetic predispositions to prostate cancer
    Cussenot, O
    Valeri, A
    Berthon, P
    Fournier, G
    Mangin, P
    UROLOGIA INTERNATIONALIS, 1998, 60 : 30 - 34
  • [9] Therapeutic targets for metastatic prostate cancer
    Timme, TL
    Satoh, T
    Tahir, SA
    Wang, HY
    Teh, BS
    Butler, EB
    Miles, BJ
    Amato, RJ
    Kadmon, D
    Thompson, TC
    CURRENT DRUG TARGETS, 2003, 4 (03) : 251 - 261
  • [10] Identification of diagnostic markers/candidate therapeutic targets for liver cancer using cDNA microarray.
    Cheung, ST
    Chen, X
    Fan, ST
    So, S
    Ng, IO
    Brown, P
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3691S - 3691S
12345